Literature DB >> 9453562

N-methyl-D-aspartate receptor desensitisation is neuroprotective by inhibiting glutamate-induced apoptotic-like death.

A M Wood1, D R Bristow.   

Abstract

Glutamate excitotoxicity is implicated in several neurodegenerative diseases; consequently, considerable effort has been made to elucidate neuroprotective mechanisms against such toxicity. N-Methyl-D-aspartate (NMDA) receptor desensitisation is one potential mechanism for controlling glutamate-mediated neuronal cell death. Pretreatment of rat cerebellar granule cells with subtoxic concentrations of NMDA caused a marked reduction in the calcium signals generated by subsequent glutamate stimulation, and, furthermore, this receptor desensitisation was coupled to a reduction in glutamate-induced apoptotic-like death. These effects were reduced by either D-2-amino-5-phosphonopentanoic acid, an NMDA receptor antagonist, or cyclosporin A, an inhibitor of calcineurin. Thus, the results support a role for receptor desensitisation in protection from glutamate-mediated apoptotic-like neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453562     DOI: 10.1046/j.1471-4159.1998.70020677.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

2.  Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.

Authors:  Qinghang Liu; Benjamin J Wilkins; Yong J Lee; Hidenori Ichijo; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin.

Authors:  T J Cunningham; L Hodge; D Speicher; D Reim; C Tyler-Polsz; P Levitt; K Eagleson; S Kennedy; Y Wang
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury.

Authors:  J E Springer; R D Azbill; S A Nottingham; S E Kennedy
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury.

Authors:  Andrew M Slupe; Ronald A Merrill; Kyle H Flippo; Mark A Lobas; Jon C D Houtman; Stefan Strack
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

6.  Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

Authors:  Georges Mion; Thierry Villevieille
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

Review 7.  Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Authors:  Hai-Jun Gao; Peng-Fei Liu; Pei-Wen Li; Zhuo-Yan Huang; Feng-Bo Yu; Ting Lei; Yong Chen; Ye Cheng; Qing-Chun Mu; Hai-Yan Huang
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

Review 8.  Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review.

Authors:  Yue Liu; Guang Yang; Wenqiang Cui; Yunling Zhang; Xiao Liang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

9.  Procyanidin B2 Protects Neurons from Oxidative, Nitrosative, and Excitotoxic Stress.

Authors:  Taylor C Sutcliffe; Aimee N Winter; Noelle C Punessen; Daniel A Linseman
Journal:  Antioxidants (Basel)       Date:  2017-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.